Benzinga's Top Upgrades

Morgan Stanley upgraded Vertex Pharmaceuticals Incorporated VRTX from Equal-weight to Overweight. The price target for Vertex Pharmaceuticals has been raised from $118 to $148. Vertex Pharmaceuticals shares closed at $107.23 on Thursday. Credit Suisse upgraded Ollie's Bargain Outlet Holdings Inc OLLI from Neutral to Outperform. The price target for Ollie's Bargain Outlet is set to $20. Ollie's Bargain Outlet shares closed at $16.08 on Thursday. Analysts at Goldman Sachs upgraded Finish Line Inc FINL from Sell to Neutral. The price target for Finish Line is set to $20. Finish Line shares closed at $18.92 on Thursday. Analysts at Morgan Stanley upgraded Pfizer Inc. PFE from Equal-weight to Overweight. The price target for Pfizer has been raised from $35 to $38. Pfizer shares closed at $31.84 on Thursday. UBS upgraded BlackRock, Inc. BLK from Neutral to Buy. The price target for BlackRock has been lowered from $370 to $350. BlackRock shares closed at $295.92 on Thursday. Analysts at Longbow Research upgraded Martin Marietta Materials, Inc. MLM from undefined to Buy. Martin Marietta Materials shares closed at $156.72 on Thursday. Analysts at Oppenheimer upgraded Google Inc GOOG from Perform to Outperform. The price target for Google has been raised from $670 to $700. Google shares closed at $611.29 on Thursday. UBS upgraded Northern Trust Corporation NTRS from Sell to Neutral. Northern Trust shares closed at $68.21 on Thursday. Morgan Stanley upgraded Alexion Pharmaceuticals, Inc. ALXN from Equal-weight to Overweight. The price target for Alexion Pharmaceuticals has been raised from $186 to $211. Alexion Pharmaceuticals shares closed at $157.82 on Thursday. Goldman Sachs upgraded Summit Materials Inc SUM from Neutral to Buy. The price target for Summit Materials is set to $29. Summit Materials shares closed at $19.68 on Thursday.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm
Posted In: UpgradesAnalyst Ratingstop upgrades
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!